Learn more about the role of Tuberculosis in cancer and how a simple vaccine supports the immune system to fight it.

There are three types of intravesical immunotherapies for bladder cancer: BCG treatment is the most common immunotherapy for cancer and is often the first-line option for bladder cancer.

Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...

Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials ...

ImmunityBio, Inc.’s IBRX share price has surged by 20.86%, which has investors questioning if this is right time to sell.

The following is a summary of “Factors predicting local or systemic side effects related to intravesical BCG (Bacillus Calmette-Guérin) therapy: a retrospective observational study,” published in the ...

Discover how a TB vaccine could revolutionise bladder cancer treatment. Find out more about this groundbreaking study.